Tumor targeted pro-apoptotic peptide

This tumor-targeting pro-apoptotic peptide, CNGRC-GG-D (KLAKLAK) 2, acts as an anti-cancer agent by disrupting mitochondrial membranes to induce programmed cell death. It has demonstrated efficacy in murine models, supporting its use in oncology research for studying targeted apoptosis in both in vitro and in vivo experimental systems.